JP2015531348A5 - - Google Patents

Download PDF

Info

Publication number
JP2015531348A5
JP2015531348A5 JP2015531567A JP2015531567A JP2015531348A5 JP 2015531348 A5 JP2015531348 A5 JP 2015531348A5 JP 2015531567 A JP2015531567 A JP 2015531567A JP 2015531567 A JP2015531567 A JP 2015531567A JP 2015531348 A5 JP2015531348 A5 JP 2015531348A5
Authority
JP
Japan
Prior art keywords
seq
peptide according
peptide
amyloid
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015531567A
Other languages
English (en)
Japanese (ja)
Other versions
JP6345670B2 (ja
JP2015531348A (ja
Filing date
Publication date
Priority claimed from DE102012108598.6A external-priority patent/DE102012108598A1/de
Application filed filed Critical
Publication of JP2015531348A publication Critical patent/JP2015531348A/ja
Publication of JP2015531348A5 publication Critical patent/JP2015531348A5/ja
Application granted granted Critical
Publication of JP6345670B2 publication Critical patent/JP6345670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015531567A 2012-09-14 2013-09-13 D3から誘導されたd−エナンチオマーの新規ペプチド及びその使用 Active JP6345670B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102012108598.6 2012-09-14
DE102012108598.6A DE102012108598A1 (de) 2012-09-14 2012-09-14 Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung
PCT/EP2013/068992 WO2014041115A2 (de) 2012-09-14 2013-09-13 Neue, von d3 abgeleitete d-enantiomere peptide und deren verwendung

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018098517A Division JP6611858B2 (ja) 2012-09-14 2018-05-23 D3から誘導されたd−エナンチオマーの新規ペプチド及びその使用

Publications (3)

Publication Number Publication Date
JP2015531348A JP2015531348A (ja) 2015-11-02
JP2015531348A5 true JP2015531348A5 (https=) 2016-11-04
JP6345670B2 JP6345670B2 (ja) 2018-06-20

Family

ID=49354628

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015531567A Active JP6345670B2 (ja) 2012-09-14 2013-09-13 D3から誘導されたd−エナンチオマーの新規ペプチド及びその使用
JP2018098517A Active JP6611858B2 (ja) 2012-09-14 2018-05-23 D3から誘導されたd−エナンチオマーの新規ペプチド及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018098517A Active JP6611858B2 (ja) 2012-09-14 2018-05-23 D3から誘導されたd−エナンチオマーの新規ペプチド及びその使用

Country Status (9)

Country Link
US (3) US20150307552A1 (https=)
EP (2) EP2895867B1 (https=)
JP (2) JP6345670B2 (https=)
CN (2) CN104704371B (https=)
DE (1) DE102012108598A1 (https=)
DK (2) DK3346273T5 (https=)
ES (2) ES2938773T3 (https=)
PL (1) PL3346273T3 (https=)
WO (1) WO2014041115A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012108598A1 (de) * 2012-09-14 2014-04-10 Forschungszentrum Jülich GmbH Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung
DE102015003676A1 (de) 2015-03-20 2016-09-22 Forschungszentrum Jülich GmbH Fachbereich Patente Spezifisch A-Beta Spezies bindende Peptide für die Therapie und/oder die Diagnose der Alzheimerschen Demenz
DE102015003503A1 (de) * 2015-03-20 2016-09-22 Forschungszentrum Jülich GmbH Spezifisch Amyloid-Beta bindende Peptide und deren Verwendung für die Therapie und Diagnose der Alzheimerschen Demenz
DE102016125645A1 (de) * 2016-12-23 2018-06-28 Forschungszentrum Jülich GmbH D-enantiomere Peptide zur Therapie von chronischem und neuropathischem Schmerz
EP3691670A4 (en) * 2017-10-02 2021-08-04 Cedars-Sinai Medical Center METHODS AND COMPOSITIONS FOR EFFECTIVE ADMINISTRATION ACROSS MULTIPLE BIOLOGICAL BARRIERS
DE102021121435A1 (de) * 2021-08-18 2023-02-23 Priavoid Gmbh Aß-BINDENDE SUBSTANZEN

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE355374T1 (de) * 2000-11-27 2006-03-15 Praecis Pharm Inc Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
JPWO2002081515A1 (ja) * 2001-04-03 2004-07-29 協和醗酵工業株式会社 インスリン様増殖因子結合蛋白質
DE10117281A1 (de) 2001-04-06 2002-10-24 Inst Molekulare Biotechnologie Peptid zur Diagnose und Therapie der Alzheimer-Demenz
US20050158306A1 (en) * 2004-01-16 2005-07-21 Halikas James A. Treatment for neuro-degenerative disease by a blood cleansing system using monoclonal antibodies
AT500483B1 (de) * 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
US20070092508A1 (en) * 2005-10-21 2007-04-26 Recombiant Technologies, Llc Detoxification depot for Alzheimer's disease
WO2010062570A2 (en) * 2008-10-27 2010-06-03 Recombinant Technologies Llc COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE
DE102008037564A1 (de) * 2008-11-19 2010-05-20 Forschungszentrum Jülich GmbH Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden
DE102010017130B4 (de) 2010-05-28 2018-11-29 Forschungszentrum Jülich GmbH Hybrid-Verbindung, deren Verwendung und Verfahren zu deren Herstellung
EP2834644B1 (de) * 2012-04-05 2019-08-21 Forschungszentrum Jülich GmbH Polymere, enthaltend multivalente amyloid-beta-bindende d-peptide und deren verwendung
DE102012108598A1 (de) * 2012-09-14 2014-04-10 Forschungszentrum Jülich GmbH Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung
DK2834643T3 (da) * 2012-04-05 2020-02-03 Forschungszentrum Juelich Gmbh Fremgangsmåde til behandling af blod, blodprodukter og organer

Similar Documents

Publication Publication Date Title
JP2015531348A5 (https=)
Mohajeri et al. Carbon nanomaterials and amyloid-beta interactions: potentials for the detection and treatment of Alzheimer's disease?
JP2010531992A5 (https=)
IN2014DN05670A (https=)
CY1123304T1 (el) Αναστολη πεπτιδιων που προερχονται απο μεταγραφημα 1 τυπου trem (tlt-1) και χρησεις αυτωn
CY1118374T1 (el) ΣΥΝ-ΚΡΥΣΤΑΛΛΟΙ ΤΡΑΜΑΔΟΛΗΣ KAI NSAIDs
JP2009225798A5 (https=)
TWI455721B (zh) 癌疫苗組合物
JP2010166916A5 (https=)
MX2011010353A (es) Composicion farmaceutica.
CY1119376T1 (el) Αντισωματα ειδικα για τη μορφη πρωτοϊνιδιου της βητα-αμυλοειδους πρωτεϊνης
SG10201907522QA (en) Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CY1117326T1 (el) Παραγωγο κατεχολαμινης χρησιμο για τη θεραπεια ασθενειας parkinson
JP2017529097A5 (https=)
JP2016525095A5 (ja) 環状ポリペプチド
JP2015164424A5 (https=)
MX2020005810A (es) Anticuerpos anti-alfa sinucleina.
HRP20190752T1 (hr) Novo protutijelo protiv ljudskog receptora tslp
WO2015086686A3 (en) Protease resistant peptides
WO2013096868A3 (en) Saposin-a derived peptides and uses thereof
BR112013032088A2 (pt) "polipeptídeo, composição farmacêutica e seu uso"
JP2016539911A5 (https=)
EA202190310A1 (ru) Белок для лечения воспалительных заболеваний
JP2017505772A5 (https=)
CY1114345T1 (el) Βελτιωμενα μορια προσδεσης του nogo-a και φαρμακευτικη χρηση αυτων